Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.4K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.4K
Wilcoxon Signed-Ranks Test for Matched Pairs01:09

Wilcoxon Signed-Ranks Test for Matched Pairs

583
The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
583
Cancer Survival Analysis01:21

Cancer Survival Analysis

822
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
822
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

480
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
480

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reset for menopause treatment.

Annals of internal medicine·2026
Same author

Physicians chart new path into direct primary care.

Medical economics·2016
Same author

Surviving the transition from independent to employed.

Medical economics·2016
Same author

Cooperate, don't compete, with retail clinics.

Medical economics·2016
Same author

UK Groups Plan Cancer Research Hub.

Cancer discovery·2016
Same author

Expanding the Scope of ENCODE.

Cancer discovery·2016
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same journal

Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates.

Cancer discovery·2026
Same journal

The Promise of Machine Learning-Based Population Screening for Hepatocellular Carcinoma.

Cancer discovery·2026
Same journal

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution.

Cancer discovery·2026
Same journal

Oral Regimens for AML Make Strides.

Cancer discovery·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
12:32

Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

Published on: September 7, 2021

2.7K

NCI-MATCH Trial Draws Strong Interest.

Janet Colwell

    Cancer Discovery
    |February 21, 2016
    PubMed
    Summary
    This summary is machine-generated.

    The National Cancer Institute (NCI) MATCH trial, a precision oncology study, has paused enrollment after successfully enrolling 800 patients. The trial will resume in April or May for its next phase.

    More Related Videos

    An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
    07:58

    An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

    Published on: May 12, 2020

    7.6K
    Associated Chromosome Trap for Identifying Long-range DNA Interactions
    14:49

    Associated Chromosome Trap for Identifying Long-range DNA Interactions

    Published on: April 23, 2011

    15.0K

    Related Experiment Videos

    Last Updated: Mar 25, 2026

    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
    12:32

    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

    Published on: September 7, 2021

    2.7K
    An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
    07:58

    An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

    Published on: May 12, 2020

    7.6K
    Associated Chromosome Trap for Identifying Long-range DNA Interactions
    14:49

    Associated Chromosome Trap for Identifying Long-range DNA Interactions

    Published on: April 23, 2011

    15.0K

    Area of Science:

    • Oncology
    • Genetics
    • Clinical Trials

    Background:

    • The NCI-MATCH trial is a large-scale precision medicine study matching cancer patients to targeted therapies based on tumor genetic mutations.
    • Enrollment recently surpassed 800 patients within the first three months, indicating significant interest and demand.

    Discussion:

    • A temporary halt in enrollment has been implemented to prepare for the trial's subsequent phase.
    • This pause allows for logistical and operational adjustments to ensure the smooth continuation of the study.

    Key Insights:

    • The trial's rapid enrollment highlights the growing importance of genomic-driven cancer treatment strategies.
    • The NCI-MATCH trial exemplifies a novel approach to cancer therapy by targeting specific molecular alterations.

    Outlook:

    • The study is anticipated to resume enrollment in April or May.
    • The next phase will likely focus on expanding patient cohorts or introducing new treatment arms based on ongoing research.